Jan. 30, 2009--The FDA posted on its web site yesterday a letter sent to Abbott Laboratories about its review of a Depakote ER/Depakote Continuum Care Pharmacy Formulary Flashcard (744-160303) (Flashcard) for Depakote (divalproex sodium delayed-release) Tablets and Depakote ER (divalproex sodium extended-release) Tablets.
The details can be read here.
No comments:
Post a Comment